University of Liverpool scientists have taken a significant step towards unlocking the medical potential of a new class of potent antibiotic capable of killing "superbugs" including MRSA without detectable resistance.

The researchers have developed simplified synthetic versions of the molecule teixobactin, used by producer bacteria to kill other bacteria in soil.

They have developed and tested a unique library of synthetic versions of the "game changing" antibiotic, optimizing key features of the drug to enhance its efficacy and safety, plus enabling it to be inexpensively produced at scale.

Read more...